AKAleksey E. Klimov

Aleksey E. Klimov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aleksey E. Klimov has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Indocyanine green dose ranging in laparoscopic cholecystectomy for acute calculous cholecystitis

    by A. M. Leonovich, A. E. Klimov, M. V. Kosachenko, A. A. Barkhudarov, V. V. Gogichashvili, D. G. Safronova, E. S. Aliev, A. V. Burlakova

    Aim . To determine the optimal dose and timing of indocyanine green for fluorescein cholangiography in laparoscopic cholecystectomy for patients with acute calculous cholecystitis. Material and methods . From March 2024 to February 2025, a prospective, non-randomized study of indocyanine green for fluorescein cholangiography in laparoscopic cholecystectomy was conducted in 197 patients with acute cholecystitis. Various doses of indocyanine green (1.25–10 mg) were administered at various times prior to surgery: from 40 min to 6 h and intraoperatively. The fluorescence intensity, time of optimal mapping of hepatoduodenal ligament structures, and ability to safely perform surgery were assessed. Results. A dose of 5 mg indocyanine green provides an optimal effect within 3–6 h after administration. A dose of 2.5 mg indocyanine green shows the best effect within 1–3 h. When 1.25 mg of indocyanine green is administered 40–90 min before surgery, sufficient fluorescence can be achieved; however, adjustments to the equipment settings are required. Intraoperative 1.25–2.5 mg administration of the drug ensures a rapid examination of the ducts; however, accompanying hyperfluorescence hampers tissue differentiation. Conclusion . ICG fluorescence cholangiography is a safe and effective method of intraoperative navigation. Optimal doses are 2.5 and 5 mg administered 1–3 and 3–5 h before surgery, respectively. A dose of 1.25 mg may be administered pre- or intraoperatively for at least 1.5 h.

  • Advantages of minilaparoscopic access in comparison with standard laparoscopic access during cholecystectomy

    by M.V. Kosachenko, A.E. Klimov, A.A. Barkhudarov, D.G. Safronova, A.V. Burlakova

    Objective. The aim of the study was to evaluate the advantages of access and the use of needlescopic instruments with a diameter of 3 mm in comparison with traditional laparoscopic access during cholecystectomy. Material and methods. The study was performed at the Department of Faculty Surgery of the RUDN Medical Institute on the basis of the V.V. Vinogradov Clinical Hospital. The prospective follow-up included 46 patients hospitalized at the V.V. Vinogradov Clinical Hospital as planned with a diagnosis of cholelithiasis. The average age of the study group was 57.4 ±15.3 years, 65% of women, 5 patients previously had biliary tract surgery. During the first five months of the study, 23 patients underwent mini-laparoscopic cholecystectomy (MLC) and were considered the main study group. Over the next five months, a control group was collected, it included 23 patients with cholelithiasis, who underwent cholecystectomy with traditional laparoscopic access. Results. The average duration of the operation in the main group was 52.8±14.8 minutes, in the control group 45.4±14.5 minutes, but this difference did not reach statistical significance (p>0.05). There were no intraoperative complications of surgical intervention in any of the groups. There was a tendency to reduce the length of hospital stay in the main group: the average bed-day in the main group was 3.3±0.8 bed-days, in the control group 3.8±1.2 bed-days (p>0.05). In the main group, the pain syndrome (assessed on a visual analog scale (VAS) from 0 to 10 points) in the early postoperative period was less pronounced than in the control group, while every fourth patient in the MLC group had no pain syndrome. Conclusion. Minilaparoscopic cholecystectomy is associated with less pronounced pain syndrome in the early postoperative period. Early activation of patients became feasible. Further, MLC reduced need for nonsteroidal anti-inflammatory drugs, shorter hospital stays, and hence the duration of temporary disability. Moreover, MLC showed better cosmetic results in the long term. Thus, if technically possible, preference should be given to minimally invasive interventions, especially in patients of working age.

  • Open Access

    Optimization of fluorescence imaging with ICG in calculous cholecystitis

    by Mikhail Kosachenko, Aleksandr Leonovich, Aleksei Klimov, Anna Burlakova

    Optimization of fluorescence imaging with ICG in calculous cholecystitis Оптимизация флуоресцентной визуализации с ICG при калькулезном холецистите

  • The effectiveness of extracorporeal techniques detoxification in pancreatic encephalopathy in a patient with pancreatic necrosis (Clinical case)

    by D. T. Nazarov, M. Yu. Persov, A. E. Klimov, E. Yu. Sadovnikova, I. V. Damulin, A. A. Strutsenko

    Pancreatic encephalopathy, characterized by a variety of focal neurological symptoms, develops in 9–35 % of patients with pancreatic diseases. Almost every patient with acute pancreatitis has a risk of developing pancreatic encephalopathy, which significantly deteriorates the course and increases mortality to 54 %. The article provides an example of the effect of extracorporeal detoxification techniques (ECDT) on the course of pancreatic necrosis, a phenomenon with neurological symptoms. The usage of ECDT is an effective method for treating pancreatic necrosis; it allows for the relief of neurological disorders caused by the development of pancreatic encephalopathy, and prevents the development, as well as helps to relieve the phenomenon of dementia of pancreatic genesis.

  • Comparative analysis of laparoscopic cholecystectomy outcomes in acute calculous cholecystitis: importance of indocyanine green, optimal dosing regimen

    by A.E. Klimov, A.M. Leonovich, M.V. Kosachenko, A.A. Barkhudarov, V.V. Gogichashvili

    Objective. To show the effectiveness of the indocyanine green application in laparoscopic cholecystectomy of any complexity. Material and methods. Our study used a domestically produced drug, namely indocyanine green, lyophilisate, which was diluted in water for injections. In addition, 4K equipment with the possibility of fluorescence of different manufacturers (Arthrex, ELEPS, KARL STORZ) was used. The study group included 117 patients who were urgently hospitalized with acute calculous cholecystitis diagnosis. All patients were additionally examined in the preoperative period according to the recommendations of the Ministry of Health of the Russian Federation. The control group included 109 patients. A retrospective analysis of the medical records for 2023 was carried out. Results. The advantages of using indocyanine green in the performance of laparoscopic cholecystectomy of any complexity were confirmed. The drug application promotes the extrahepatic biliary tracts navigation, thus allowing to avoid the injuries of extrahepatic bile ducts and the consequences of these injuries. In addition, its implementation increases the possibility of early training of young professionals and residents on the technique of safe laparoscopic cholecystectomy. Conclusions. The application of optimal dosages of indocyanine does not cause visual discomfort during the operation, significantly reduces the duration of the surgery, thus allowing to reduce the time spent in the hospital in the postoperative period.


  • Experience of indocyanine green use in acute calculous cholecystitis

    by A.E. Klimov, A.M. Leonovich, M.V. Kosachenko, A.A. Barkhudarov

    Objective. To assess the safety and effectiveness of the indocyanine green use in acute cholecystitis for identification of anatomical variants of the biliary tree; prevention and timely detection of intraoperative complications. Material and methods. The medication of indocyanine green made by OOO «Ferment» domestic manufacturer was used. The drug dose from 2.5 mg to 10 mg was applied according to studied materials (8). Time of the surgery beginning was from 2 to 6 hours after intravenous injection of aqueous solution, respectively. In addition, it has been established that the optimal drug dose is 5 mg. The surgery should be performed not earlier than 3 hours after, but no later than 6 hours. This allows to achieve the most comfortable fluorescence of the extrahepatic biliary tract. The drug concentration in the liver cells decreases by this time and increases in the biliary tract. It is not always possible to perform the operation strictly within the specified time limit considering the urgency of the surgical intervention. In this connection, the surgery was carried out not earlier than 3 hours after the drug injection, but not later than 6 hours. Endoscopic equipment with the ability to display near-infrared fluorescence was used. A laser light source with a wavelength of 820 nm in the Arthrex imaging system with 4K resolution as well as the Olympus imaging system with HD resolution were used for fluorescence excitation. Results. The implementation of intraoperative fluorescent navigation with indocyanine green contributes to the improvement of safety and effectiveness of surgical treatment through visualization of topography and identification of anatomical variants of the biliary tree; possibilities of prevention and timely detection of intraoperative complications. The use of indocyanine green allows to intraoperatively reveal atypical location and different variations of the extrahepatic biliary tract.


  • Palliative large-bowel decompression for colorectal obstruction in patients with unresectable locally advanced cancer and carcinomatosis

    by S.V. Davydova, A.G. Fedorov, O.A. Yun, A.E. Klimov

    OBJECTIVE Evaluation clinical outcomes of stenting and decompressive surgery in patients with colorectal obstruction due to unresectable locally advanced cancer and carcinomatosis. MATERIAL AND METHODS A retrospective analysis of palliative treatment of 73 patients with large-bowel obstruction was performed. Criterion of inclusion — presence of unresectable primary, recurrent or metastatic locally advanced tumour with invasion to adjacent tissues and/or peritoneal dissemination. Patients underwent colorectal stenting (39) or decompressive surgery (34) (loop colostomy — 29, ileotransverse bypass — 5). Left-sided obstruction was observed in 64 (35/29) patients, right-sided — in 9 (4/5) patients. Location of tumour: colorectal cancer — 57 (29/28), extracolonic tumour — 16 (10/6) patients. RESULTS Complications occurred in 3 patients (7.7%) after stenting and in 11 (32.4%) after surgical palliation (p=0.0083) with post-procedure mortality 5.1% (2 patients) vs. 14.7% (5 patients), p=0.2675. Stoma complications and wound infection prevailed among surgical adverse events; all stent-related complications included bowel perforation. General adverse events were observed in 5 patients after colostomy vs. 0 after stenting (p=0.0185). Hospital stay was shorter for stenting (p=0.0010). CONCLUSION Stenting and loop colostomy or bypass appear to be equally effective for management of large bowel obstruction in patients with locally advanced unresectable cancer of various etiology, including extracolonic, recurrent and metastatic tumours. In comparison to decompressive surgery colorectal stenting is less invasive, has an advantage of fewer adverse events, shorter hospital stay, absence of stoma and therefore may be recommended as a final palliation.

  • Minilaparoscopic total extraperitoneal hernioplasty

    by M. V. Kosachenko, City Clinical Hospital Named After V. V. Vinogradov, A. E. Klimov, A. A. Barkhudarov, D. G. Safronova, Peoples’ Friendship University of Russia named after Patrice Lumumba

  • Open Access

    Urgent total pancreatoduodenectomy for profuse gastro-intestinal bleeding caused by renal cancer metastases to the pancreas

    by Andrey G. Mylnikov, Aleksey E. Klimov, Temurbek Sh. Kurbanniyozov, Nina V. Bujmestru, Anna A. Chernjaeva, Tatyana A. Gusarova

    Renal cancer (RC) can spread to different organs, metastatic damage of the pancreas is quite rare. But, in contrast of primary and other metastatic malignant tumors, pancreatic RC metastases can be resectable in 80 % of cases with nearly 90 % 5-year survival rate. Pancreatic oncologic surgery includes 3 different types of resection: distal pancreatic resection, pancreatoduodenal resection and total duodenopancreatectomy. The last type is the most extensive procedure, incorporates except of total removal of the pancreatic gland, total excision of duodenum and, in some cases, partial gastrectomy. In surgery of pancreatic tumors using of total duodenopancreatectomy is relatively rare (6,7-12,3 %). And in spite of low mortality (5-6,25 %) in recent years, whole removal of the gland inevitably leads to severe metabolic changes such as complete exocrine insufficiency and unstable insulin-depended diabetes mellitus which need lifetime medical correction. Gastrointestinal bleeding from pancreatic metastases of RC as a disease complication occurs quite rare and appears due to invasion of cancer tissue located in the pancreatic head to duodenal mucosa and then ulcerated. There are few single observations or little series (2-4 cases) described in literature. Pancreatoduodenal resection in such cases is the main type of surgical intervention. Now we present a case of successful urgent total duodenopancreatectomy, performed for recurrent profuse gastrointestinal bleeding from pancreatic head metastasis of RC invaded duodenum after previously radical nephrectomy. During the operation several cancer nodes in the pancreatic body and tail were found that defined the total gland removal. Postoperative period proceeded uneventfully and the patient was discharged on 15th day. Uniqueness of this case is that emergency total duodenopancreatectomy was successfully done for profuse gastrointestinal bleeding as the only possible chance for cure. We have not found similar reports in the available literature.


  • Clinical outcomes of colorectal stenting

    by S.V. Davydova, A.G. Fedorov, O.A. Yun, A.E. Klimov

    Objective. The aim of retrospective study was to evaluate early and long-term outcomes of colorectal stenting. Material and methods. 101 patients presenting with symptomatic colorectal obstruction at the period of 2010—2020 underwent an attempt of stenting. Stenosis due to colorectal cancer (92) or extracolonic malignancies (9) was located in left half of large bowel in 85 patients (rectum and rectosigmoid — 43, left colon — 42), in right colon — in 16 patients. Effectiveness of stent placement, adverse events and survival were analyzed. Results. Technical and functional success of stenting was achieved in 99 patients (98%). Attempt of stent placement failed in 2 cases of ascending colon cancer, technical success in right colon — 88%. Early complications were observed in 8 patients (7.9%): colonic perforation with peritonitis (3), extraperitoneal rectal perforation (1), pelvic abscess in combination with stent dislocation (1), and distal migration of covered stents (3). 3 perforations at the tumor site occurred on the first-second days, one was delayed and revealed on the 11th day after procedure. Two cases of peritonitis resulted in death, stent-associated mortality — 2%. 3 patients underwent radical resections. Recurrence of obstructive symptoms due to stent occlusion in 8—20 months after palliative stenting occurred in 4 patients. Conclusion. Stenting is a valid technique to treat malignant colorectal obstruction. The main complication in cases of locally advanced cancer is bowel perforation. Placement of covered stents is associated with an increased risk of migration.